Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - metoprolol tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - metoprolol tartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - metoprolol tartrate -

United States - English - NLM (National Library of Medicine)

hospira, inc. - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - metoprolol tartrate 1 mg in 1 ml - metoprolol tartrate injection is indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used in conjunction with oral metoprolol tartrate maintenance therapy. treatment with intravenous metoprolol tartrate can be initiated as soon as the patient's clinical condition allows (see dosage and administration,  contraindications , and warnings ). hypersensitivity to metoprolol tartrate and related derivatives, or to any of the excipients; hypersensitivity to other beta-blockers (cross sensitivity between beta-blockers can occur). metoprolol tartrate is contraindicated in patients with a heart rate <45 beats/min; second- and third-degree heart block; significant first-degree heart block (p-r interval ≥0.24 sec); systolic blood pressure <100 mmhg; or moderate-to-severe cardiac failure (see warnings ).

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - captopril - oral solution - captopril 5 mg/5ml - agents acting on the renin-angiotensin system

Malta - English - Medicines Authority

syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - captopril - oral solution - captopril 25 mg/5ml - agents acting on the renin-angiotensin system

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 100 mg - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; lactose monohydrate; macrogol 400; pregelatinised maize starch; titanium dioxide; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; purified talc; colloidal anhydrous silica - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 50 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; hypromellose; magnesium stearate; iron oxide red; croscarmellose sodium; macrogol 400; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; purified talc; pregelatinised maize starch - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 100 mg - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; lactose monohydrate; macrogol 400; pregelatinised maize starch; titanium dioxide; magnesium stearate; sodium starch glycollate; microcrystalline cellulose; purified talc; colloidal anhydrous silica - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 50 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; hypromellose; magnesium stearate; iron oxide red; croscarmellose sodium; macrogol 400; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; purified talc; pregelatinised maize starch - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.